Wednesday, April 16, 2025

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

from Top Health News -- ScienceDaily https://ift.tt/eDV8R6n

No comments:

Post a Comment

Ozempic changed obesity treatment, but experts say the real revolution is next

The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now env...